Results 251 to 260 of about 43,089 (386)

Diagnosing HFpEF

JACC: Cardiovascular Imaging, 2018
openaire   +3 more sources

Nurse‐coordinated multidisciplinary comprehensive heart failure management programme: A propensity‐matched trial

ESC Heart Failure, EarlyView.
Abstract Aims Despite therapeutic advancements, the prognosis of heart failure (HF) remains poor, with high rates of mortality and readmission, particularly following a HF exacerbation. This study aimed to evaluate the effects of a nurse‐coordinated multidisciplinary comprehensive HF management programme on HF patients.
Cecilia Miu‐Ching Chan, Polly Wai‐Chi Li, Derek Pok‐Him Lee, Esmond Yan‐Hang Fong, Ivy Sin‐Yee Ng, Samantha Ki‐Man Chiu, Clara Woon‐Shan Fok, Frederick Kin‐Wa Li, Shirley Ka‐Wai Lee, Karen K. Y. Ho, Wilson Y. S. Leung, Cathy Cheuk‐Sum Chan, Cindy Yiu‐Ning Tsang, Michael Kang‐Yin Lee   +13 more
wiley   +1 more source

Heart failure with preserved ejection fraction and obesity: emerging metabolic therapeutic strategies. [PDF]

Diabetol Metab Syndr
Zheng W, Qi Q, Li J, He C, Fan H.
europepmc   +1 more source

TREATMENT OF A HFPEF MOUSEMODEL WITH CARVEDILOL, SALBUTAMOL OR EXERCISE

, 2020
Julian C. Dunkley, Camila Iansen Irion, Keyvan Yousefi, Serene A. Shehadeh, Jeffrey J. Goldberger, Lina A. Shehadeh   +5 more
openalex   +1 more source

Association of baseline and longitudinal changes in insulin‐like growth factor‐binding protein‐7 with the risk of incident heart failure: Data from the PREVEND study

European Journal of Heart Failure, EarlyView.
Insulin‐like growth factor‐binding protein‐7 (IGFBP7) and heart failure (HF) risk: the PREVEND study. CI, confidence interval; HR, hazard ratio. Abstract Aim Senescence is a major risk factor for heart failure (HF), and insulin‐like growth factor‐binding protein‐7 (IGFBP7) has been identified as an important senescence‐inducing factor.
Sabrina Abou Kamar, Valentina Bracun, Maissa El‐Qendouci, Nils Bomer, Stephan J.L. Bakker, Ron T. Gansevoort, Eric Boersma, Isabella Kardys, Rudolf A. de Boer, Navin Suthahar   +9 more
wiley   +1 more source

Applicability and Clinical Utility of Framingham and NHANES criteria in HFrEF HFpEF and Combined HF

, 2019
Dhanasegaran Sivanesan Egambaram, N. Swaminathan, S. Venkatesan   +2 more
openalex   +1 more source

Lebensqualität in einem Risikokollektiv für HFpEF: Einflussgrößen auf die Lebensqualiät und Assoziationen verschiedener Aspekte der Lebensqualität auf den klinischen Verlauf der Patienten - Ergebnisse der Diast-CHF-Studie -

, 2021
Xenia Miriam Anna Taylor
openalex   +1 more source

The Mayo ATTR‐CM score versus other diagnostic scores and cardiac biomarkers in patients with suspected cardiac amyloidosis

European Journal of Heart Failure, EarlyView.
Proposed algorithm to screen for transthyretin cardiac amyloidosis (ATTR‐CA). AL‐CA, immunoglobulin light‐chain cardiac amyloidosis; AMYLI, AMYLoidosis Index; AUC, area under the curve; IWT, increased wall thickness; LVEF, left ventricular ejection fraction; PYP, pyrophosphate.
Giovanni Battista Bonfioli, Daniela Tomasoni, Giuseppe Vergaro, Vincenzo Castiglione, Marianna Adamo, Iacopo Fabiani, Victor Loghin, Carlo Mario Lombardi, Alessio Nicolai, Marco Metra, Michele Emdin, Alberto Aimo   +11 more
wiley   +1 more source

Integrated Systems Biology Identifies Disruptions in Mitochondrial Function and Metabolism as Key Contributors to HFpEF. [PDF]

JACC Basic Transl Sci
Gibb AA, LaPenna K, Gaspar RB, Latchman NR, Tan Y, Choya-Foces C, Doiron JE, Li Z, Xia H, Lazaropoulos MP, Conwell M, Sharp TE, Goodchild TT, Lefer DJ, Elrod JW.   +14 more
europepmc   +1 more source

HDACs as a therapeutic target in HFpEF [PDF]

Nature Reviews Cardiology, 2020
openaire   +3 more sources